- call +1-201-465-4211
- email sales@mrinsights.biz
Kidney cancer is a type of cancer that starts in the cells in the kidney.
Scope of the Report:
The growth of the market is attributed to increasing incidence of kidney cancers and increasing ill lifestyle changes which gets worsen with addiction of tobacco and alcohol. Furthermore, overexposure to radiation during treatment testicular cancer, growing awareness program, and increasing mortality due to kidney cancer are boosting the kidney cancer market.
The global Kidney Cancer market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Kidney Cancer.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Kidney Cancer market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Kidney Cancer market by product type and applications/end industries.
Market Segment by Companies, this report covers
Merck
Novartis
AstraZeneca
Bristol-Myers Squibb
Pfizer
Roche
Amgen
Argos Therapeutics
Aveo Pharmaceuticals
Bayer
Exelixis
Incyte
Allergan
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Renal Cell Carcinoma (RCC)
Transitional Cell Carcinoma (TCC)
Market Segment by Applications, can be divided into
Surgery
Immunotherapy
Chemotherapy
Radiation Therapy
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Kidney Cancer Market Overview
1.1 Product Overview and Scope of Kidney Cancer
1.2 Classification of Kidney Cancer by Types
1.2.1 Global Kidney Cancer Revenue Comparison by Types (2017-2023)
1.2.2 Global Kidney Cancer Revenue Market Share by Types in 2017
1.2.3 Renal Cell Carcinoma (RCC)
1.2.4 Transitional Cell Carcinoma (TCC)
1.3 Global Kidney Cancer Market by Application
1.3.1 Global Kidney Cancer Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Surgery
1.3.3 Immunotherapy
1.3.4 Chemotherapy
1.3.5 Radiation Therapy
1.4 Global Kidney Cancer Market by Regions
1.4.1 Global Kidney Cancer Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Kidney Cancer Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Kidney Cancer Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Kidney Cancer Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Kidney Cancer Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Kidney Cancer Status and Prospect (2013-2023)
1.5 Global Market Size of Kidney Cancer (2013-2023)
2 Manufacturers Profiles
2.1 Merck
2.1.1 Business Overview
2.1.2 Kidney Cancer Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Merck Kidney Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.2 Novartis
2.2.1 Business Overview
2.2.2 Kidney Cancer Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis Kidney Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.3 AstraZeneca
2.3.1 Business Overview
2.3.2 Kidney Cancer Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 AstraZeneca Kidney Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.4 Bristol-Myers Squibb
2.4.1 Business Overview
2.4.2 Kidney Cancer Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bristol-Myers Squibb Kidney Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.5 Pfizer
2.5.1 Business Overview
2.5.2 Kidney Cancer Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Pfizer Kidney Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.6 Roche
2.6.1 Business Overview
2.6.2 Kidney Cancer Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Roche Kidney Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.7 Amgen
2.7.1 Business Overview
2.7.2 Kidney Cancer Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Amgen Kidney Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.8 Argos Therapeutics
2.8.1 Business Overview
2.8.2 Kidney Cancer Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Argos Therapeutics Kidney Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.9 Aveo Pharmaceuticals
2.9.1 Business Overview
2.9.2 Kidney Cancer Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Aveo Pharmaceuticals Kidney Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.10 Bayer
2.10.1 Business Overview
2.10.2 Kidney Cancer Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Bayer Kidney Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.11 Exelixis
2.11.1 Business Overview
2.11.2 Kidney Cancer Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Exelixis Kidney Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.12 Incyte
2.12.1 Business Overview
2.12.2 Kidney Cancer Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Incyte Kidney Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.13 Allergan
2.13.1 Business Overview
2.13.2 Kidney Cancer Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Allergan Kidney Cancer Revenue, Gross Margin and Market Share (2016-2017)
3 Global Kidney Cancer Market Competition, by Players
3.1 Global Kidney Cancer Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Kidney Cancer Players Market Share
3.2.2 Top 10 Kidney Cancer Players Market Share
3.3 Market Competition Trend
4 Global Kidney Cancer Market Size by Regions
4.1 Global Kidney Cancer Revenue and Market Share by Regions
4.2 North America Kidney Cancer Revenue and Growth Rate (2013-2018)
4.3 Europe Kidney Cancer Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Kidney Cancer Revenue and Growth Rate (2013-2018)
4.5 South America Kidney Cancer Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Kidney Cancer Revenue and Growth Rate (2013-2018)
5 North America Kidney Cancer Revenue by Countries
5.1 North America Kidney Cancer Revenue by Countries (2013-2018)
5.2 USA Kidney Cancer Revenue and Growth Rate (2013-2018)
5.3 Canada Kidney Cancer Revenue and Growth Rate (2013-2018)
5.4 Mexico Kidney Cancer Revenue and Growth Rate (2013-2018)
6 Europe Kidney Cancer Revenue by Countries
6.1 Europe Kidney Cancer Revenue by Countries (2013-2018)
6.2 Germany Kidney Cancer Revenue and Growth Rate (2013-2018)
6.3 UK Kidney Cancer Revenue and Growth Rate (2013-2018)
6.4 France Kidney Cancer Revenue and Growth Rate (2013-2018)
6.5 Russia Kidney Cancer Revenue and Growth Rate (2013-2018)
6.6 Italy Kidney Cancer Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Kidney Cancer Revenue by Countries
7.1 Asia-Pacific Kidney Cancer Revenue by Countries (2013-2018)
7.2 China Kidney Cancer Revenue and Growth Rate (2013-2018)
7.3 Japan Kidney Cancer Revenue and Growth Rate (2013-2018)
7.4 Korea Kidney Cancer Revenue and Growth Rate (2013-2018)
7.5 India Kidney Cancer Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Kidney Cancer Revenue and Growth Rate (2013-2018)
8 South America Kidney Cancer Revenue by Countries
8.1 South America Kidney Cancer Revenue by Countries (2013-2018)
8.2 Brazil Kidney Cancer Revenue and Growth Rate (2013-2018)
8.3 Argentina Kidney Cancer Revenue and Growth Rate (2013-2018)
8.4 Colombia Kidney Cancer Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Kidney Cancer by Countries
9.1 Middle East and Africa Kidney Cancer Revenue by Countries (2013-2018)
9.2 Saudi Arabia Kidney Cancer Revenue and Growth Rate (2013-2018)
9.3 UAE Kidney Cancer Revenue and Growth Rate (2013-2018)
9.4 Egypt Kidney Cancer Revenue and Growth Rate (2013-2018)
9.5 Nigeria Kidney Cancer Revenue and Growth Rate (2013-2018)
9.6 South Africa Kidney Cancer Revenue and Growth Rate (2013-2018)
10 Global Kidney Cancer Market Segment by Type
10.1 Global Kidney Cancer Revenue and Market Share by Type (2013-2018)
10.2 Global Kidney Cancer Market Forecast by Type (2018-2023)
10.3 Renal Cell Carcinoma (RCC) Revenue Growth Rate (2013-2023)
10.4 Transitional Cell Carcinoma (TCC) Revenue Growth Rate (2013-2023)
11 Global Kidney Cancer Market Segment by Application
11.1 Global Kidney Cancer Revenue Market Share by Application (2013-2018)
11.2 Kidney Cancer Market Forecast by Application (2018-2023)
11.3 Surgery Revenue Growth (2013-2018)
11.4 Immunotherapy Revenue Growth (2013-2018)
11.5 Chemotherapy Revenue Growth (2013-2018)
11.6 Radiation Therapy Revenue Growth (2013-2018)
12 Global Kidney Cancer Market Size Forecast (2018-2023)
12.1 Global Kidney Cancer Market Size Forecast (2018-2023)
12.2 Global Kidney Cancer Market Forecast by Regions (2018-2023)
12.3 North America Kidney Cancer Revenue Market Forecast (2018-2023)
12.4 Europe Kidney Cancer Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Kidney Cancer Revenue Market Forecast (2018-2023)
12.6 South America Kidney Cancer Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Kidney Cancer Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Kidney Cancer Picture
Table Product Specifications of Kidney Cancer
Table Global Kidney Cancer and Revenue (Million USD) Market Split by Product Type
Fi
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
